Splash Beverage Merges with Medterra CBD to Form Public Wellness Platform

Splash Beverage Group, a publicly traded beverage company, has announced a transformative proposed merger with Medterra CBD, a leading manufacturer of federally compliant cannabinoid wellness products. This strategic combination marks Splash's re-alignment into a public cannabinoid wellness platform, aiming to leverage Medterra's established infrastructure, profitable track record of over $52 million in 2025 revenue, and its portfolio serving over 2 million customers. The core message from leadership, including Splash's Brady Cobb and Medterra's J.P. Larsen, positions this as a pivotal move to build a category-leading, scaled organization at a time of increasing regulatory clarity and institutional interest in the wellness sector. The partnership is designed to drive growth through operational scale, access to public markets, and a disciplined strategy focused on curating a house of trusted brands.

The proposed transaction is strategically timed at what management calls a regulatory and market inflection point, highlighted by federal policy developments including an executive order from December 2025 that initiated a CBD pilot initiative being evaluated by the Centers for Medicare & Medicaid Services (CMS). This initiative explores structured pathways for physician-recommended, federally compliant hemp-derived CBD products within healthcare frameworks, including potential government reimbursement models. Industry analysis suggests such reforms could unlock a U.S. market opportunity exceeding $30 billion. The combined entity, with Medterra's science-driven formulations and compliance focus, aims to be well-positioned to participate in these emerging channels while adhering to existing guidelines.

Key details include the non-binding nature of the Letter of Intent, with the transaction subject to definitive agreements and shareholder approvals. J.P. Larsen is expected to join the combined company's board and assume a senior operating role. The companies plan to file a Current Report on Form 8-K with the SEC with additional details. This news was distributed via NEWMEDIAWIRE, and readers can find more information about the companies through their respective websites. The announcement underscores a strategic pivot for Splash from a beverage portfolio to a focused wellness platform, capitalizing on Medterra's brand equity and operational capabilities to navigate and lead in the evolving cannabinoid wellness landscape.